Codex4SMEs - Companion Diagnostics expedited for SMEs
The Interreg project Codex4SMEs (Companion diagnostics expedited for small and medium-sized businesses) project plans to improve healthcare by enhanced adoption of Personalized Medicine in North-West Europe. The objective is to establish a network, which supports SMEs along the value chain of Companion diagnostics (Cdx) development.
Companion diagnostics (Cdx) are an indispensable tool for optimum application of Personalized Medicine: they allow tests to determine the molecular causes of a disease before treatment has started. However, thus far the development of companion diagnostics has been highly time-consuming and costly, so at present it is only used in the context of very few treatments.
Codex4SMEs will establish a transnational network of nine partners and two sub-partners from seven countries and expedite the development of the SMEs’ products in the field of Cdx. There is a need to improve SMEs‘ innovative capabilities and raise both international competitiveness and the impact of North-West Europe SMEs in this global market as the USA are far ahead - Codex4SMEs will directly address this challenge.
Benefits for SMEs
- Access to:
- Sample access service
- biomarker validation service
- knowledge transfer service of biomarker/biobanking
- ecosystems from 11 partners
- transnational roadshow to venture and large pharma companies
- business model and expert access service for business growth and scaling
- Tailored support dependent from the product TRL levels of the SMEs
Lead Partner: BioRegio STERN Management GmbH
Project Partners: University of Leicester (and subpartner), BOM Holding BV, WestBIC, Innovation Quarter (and subpartner), Medicen Paris Region, Integrated BioBank of Luxembourg, Biobank Graz at the Medical University of Graz, CÚRAM Centre for Research in Medical Devices.
Associated Partner: EATRIS European Infrastructure for Translational Medicine
For more information visit website www.nweurope.eu/projects/project-search/codex4smes